Inspire Medical Systems, Inc. (INSP) trades at a trailing P/E of 10.9, forward P/E of 29.6. Trailing earnings yield is 9.16%, forward earnings yield 3.38%. PEG 0.06 (Peter Lynch undervalued ≤1.0). Graham Number is $55.24.
Criteria proven by this page:
Overall SharesGrow Score: 77/100 with 4/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -16.8 | 1.31 | -47.11 | 18.95 | - |
| 2017 | -19.2 | 1.51 | 227.09 | 11.80 | - |
| 2018 | -28.2 | -1.83 | 3.76 | 12.18 | - |
| 2019 | -53.1 | 7.97 | 12.63 | 21.53 | - |
| 2020 | -85.7 | -1.52 | 21.35 | 42.50 | - |
| 2021 | -149.2 | 5.03 | 27.38 | 26.87 | - |
| 2022 | -157.5 | -40.44 | 14.26 | 17.34 | - |
| 2023 | -281.8 | 5.12 | 10.41 | 9.54 | - |
| 2024 | 103.1 | -0.29 | 8.00 | 6.87 | - |
| 2025 | 18.6 | 0.11 | 3.47 | 2.97 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-1.49 | $16.43M | $-18.53M | -112.8% |
| 2017 | $-1.30 | $28.57M | $-17.51M | -61.3% |
| 2018 | $-1.50 | $50.59M | $-21.83M | -43.1% |
| 2019 | $-1.40 | $82.05M | $-33.24M | -40.5% |
| 2020 | $-2.19 | $115.38M | $-57.2M | -49.6% |
| 2021 | $-1.54 | $233.39M | $-42.04M | -18% |
| 2022 | $-1.60 | $407.86M | $-44.88M | -11% |
| 2023 | $-0.72 | $624.8M | $-21.15M | -3.4% |
| 2024 | $1.75 | $802.8M | $53.51M | 6.7% |
| 2025 | $4.89 | $911.98M | $145.42M | 15.9% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $1.92 | $1.42 – $2.18 | $965.04M | $943.4M – $1.01B | 9 |
| 2027 | $2.49 | $1.97 – $3.36 | $1.05B | $997.98M – $1.11B | 8 |
| 2028 | $3.46 | $3.00 – $4.24 | $1.15B | $1.15B – $1.16B | 3 |
| 2029 | $4.24 | $4.05 – $4.46 | $1.28B | $1.23B – $1.33B | 1 |
| 2030 | $5.21 | $4.97 – $5.47 | $1.39B | $1.34B – $1.44B | 1 |
